
AstraZeneca/Daiichi Sankyo’s Datroway approved by EC to treat breast cancer
AstraZeneca (AZ) and Daiichi Sankyo’s Datroway (datopotamab deruxtecan) has been approved by the European Commission (EC) for use in certain cases of pre-treated breast cancer. The drug has been authorised for use in adults with unresectable or metastatic …